156 related articles for article (PubMed ID: 29466233)
21. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
Maraina CH; Nurdayana AK; Rusni D; Azwany Y
Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
[TBL] [Abstract][Full Text] [Related]
22. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.
Derganova O; Martinez-Gamboa L; Egerer K; Bang H; Fredenhagen G; Roggenbuck D; Esaulenko I; Burmester GR; Chernykh T; Feist E
Clin Exp Rheumatol; 2014; 32(5):622-9. PubMed ID: 25189876
[TBL] [Abstract][Full Text] [Related]
23. Anti-cyclic citrullinated peptide antibodies: a comparison of different assays for the diagnosis of rheumatoid arthritis.
Debaugnies F; Servais G; Badot V; Noubouossie D; Willems D; Corazza F
Scand J Rheumatol; 2013; 42(2):108-14. PubMed ID: 23126558
[TBL] [Abstract][Full Text] [Related]
24. [The specificity of anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis from a large cohort study in the Chinese].
Li T; Bao J; Yin J; Xu HJ
Zhonghua Nei Ke Za Zhi; 2011 Feb; 50(2):99-101. PubMed ID: 21418826
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of three ELISA measurements of anti-cyclic citrullinated peptide antibodies in the early diagnosis of rheumatoid arthritis.
Fernández-Suárez A; Reneses S; Wichmann I; Criado R; Núñez A
Clin Chem Lab Med; 2005; 43(11):1234-9. PubMed ID: 16232091
[TBL] [Abstract][Full Text] [Related]
26. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
Us D; Gülmez D; Hasçelik G
Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.
Vallbracht I; Rieber J; Oppermann M; Förger F; Siebert U; Helmke K
Ann Rheum Dis; 2004 Sep; 63(9):1079-84. PubMed ID: 15308516
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
Chang PY; Yang CT; Cheng CH; Yu KH
Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
[TBL] [Abstract][Full Text] [Related]
29. Anti-cyclic citrullinated peptide antibody in systemic sclerosis.
Morita Y; Muro Y; Sugiura K; Tomita Y
Clin Exp Rheumatol; 2008; 26(4):542-7. PubMed ID: 18799082
[TBL] [Abstract][Full Text] [Related]
30. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
[TBL] [Abstract][Full Text] [Related]
31. Significance of combined anti-CCP antibodies and rheumatoid factor in a New Zealand cohort of patients with systemic sclerosis.
Kamalaksha S; White DHN; Solanki KK
Int J Rheum Dis; 2018 Jul; 21(7):1430-1435. PubMed ID: 29968328
[TBL] [Abstract][Full Text] [Related]
32. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
[TBL] [Abstract][Full Text] [Related]
33. [Significance and diagnostic value of synovial fluid anti-cyclic citrullinated peptide antibody and anti-mutated citrullinated vimentin antibodies in patients with serum negative rheumatoid arthritis].
Qu SJ; Ye H; Jia RL; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):933-936. PubMed ID: 27987492
[TBL] [Abstract][Full Text] [Related]
34. Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients.
Zhu T; Feng L
Int J Rheum Dis; 2013 Apr; 16(2):157-61. PubMed ID: 23773638
[TBL] [Abstract][Full Text] [Related]
35. [Prevalence and significance of immunoglobulin G-anti-cyclic citrullinated peptide antibodies in primary Sjogren's syndrome patients].
Liu Y; Wang YF; Wang KL; Lv FF
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):478-82. PubMed ID: 24943033
[TBL] [Abstract][Full Text] [Related]
36. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S
Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
[TBL] [Abstract][Full Text] [Related]
37. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
[TBL] [Abstract][Full Text] [Related]
38. Salivary IgA antibodies to cyclic citrullinated peptides (CCP) in rheumatoid arthritis.
Svärd A; Kastbom A; Sommarin Y; Skogh T
Immunobiology; 2013 Feb; 218(2):232-7. PubMed ID: 22652412
[TBL] [Abstract][Full Text] [Related]
39. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
[TBL] [Abstract][Full Text] [Related]
40. PREVALENCE OF ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS CLASSIFIED AS RHEUMATOID AND UNDIFFERENTIATED ARTHRITIS AT KENYATTA NATIONAL HOSPITAL.
Ayunga AO; Oyoo GO; Amayo EO; Angela AA
East Afr Med J; 2012 Jun; 89(6):206-11. PubMed ID: 26856043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
